Incyte Corporation
DIHYDROPYRIDO[2,3-D]PYRIMIDINONE COMPOUNDS AS CDK2 INHIBITORS

Last updated:

Abstract:

The present application provides dihydropyrido[2,3-d]pyrimidone inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.

Status:
Application
Type:

Utility

Filling date:

10 Jun 2021

Issue date:

13 Jan 2022